We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

133 hedge funds and large institutions have $1.3B invested in Intra-Cellular Therapies Inc. in 2019 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 36 increasing their positions, 47 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

337% more capital invested

Capital invested by funds: $298M → $1.3B (+$1B)

29% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 24

6% more funds holding

Funds holding: 126 → 133 (+7)

23% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 47

53% less call options, than puts

Call options by funds: $260M | Put options by funds: $549M

Holders
133
Holders Change
+7
Holders Change %
+5.56%
% of All Funds
2.62%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.08%
New
31
Increased
36
Reduced
47
Closed
24
Calls
$260M
Puts
$549M
Net Calls
-$289M
Net Calls Change
-$278M

Top Buyers

1
CCM
Consonance Capital Management
New York
+$23.5M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$14.6M
3
ACP
Acuta Capital Partners
California
+$7.05M
4
VMI
VHCP Management III
New York
+$6.9M
5
OM
Opaleye Management
Massachusetts
+$2.84M

Top Sellers

1
WA
Wasatch Advisors
Utah
-$26.8M
2
Millennium Management
Millennium Management
New York
-$11.7M
3
SC
Samlyn Capital
New York
-$11M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$8.11M
5
ClearBridge Investments
ClearBridge Investments
New York
-$5.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
51
Russell Investments Group
United Kingdom
$1.99M +$312K +25,971 +81%
PPA
52
Parametric Portfolio Associates
Washington
$1.77M +$116K +9,667 +23%
Walleye Trading
53
Walleye Trading
New York
$1.74M +$609K +50,760 New
Ohio Public Employees Retirement System (OPERS)
54
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.72M -$749K -62,412 -55%
FSA
55
Franklin Street Advisors
North Carolina
$1.46M -$120K -10,000 -19%
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$1.41M -$32.4K -2,700 -6%
Walleye Capital
57
Walleye Capital
New York
$1.41M +$273K +22,768 +124%
UBS AM
58
UBS AM
Illinois
$1.32M -$23.6K -1,968 -5%
Simplex Trading
59
Simplex Trading
Illinois
$1.29M -$272K -22,654 -38%
PAI
60
Palo Alto Investors
California
$1.28M +$449K +37,400 New
VEA
61
Virtus ETF Advisers
New York
$1.1M +$143K +11,942 +59%
Invesco
62
Invesco
Georgia
$1.08M -$41.9K -3,492 -10%
WMSA
63
Weiss Multi-Strategy Advisers
New York
$1.03M – – –
TD Asset Management
64
TD Asset Management
Ontario, Canada
$1.03M +$360K +30,000 New
Two Sigma Investments
65
Two Sigma Investments
New York
$984K -$2.04M -170,340 -86%
Allianz Asset Management
66
Allianz Asset Management
Germany
$979K -$109K -9,042 -24%
AIG
67
American International Group
New York
$957K -$2.82K -235 -0.8%
HHAM
68
HITE Hedge Asset Management
Massachusetts
$928K +$325K +27,053 New
Manulife (Manufacturers Life Insurance)
69
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$897K -$17.6K -1,470 -5%
CS
70
Credit Suisse
Switzerland
$851K -$101K -8,405 -25%
Wells Fargo
71
Wells Fargo
California
$841K +$12K +1,002 +4%
AG
72
Aperio Group
California
$806K +$86.3K +7,192 +44%
Two Sigma Advisers
73
Two Sigma Advisers
New York
$788K -$1.39M -115,800 -83%
VOYA Investment Management
74
VOYA Investment Management
Georgia
$760K +$31.9K +2,659 +14%
State Board of Administration of Florida Retirement System
75
State Board of Administration of Florida Retirement System
Florida
$736K – – –
1 2
3
4 5

ITCI Hedge Fund Activity: Q4 2019 in Review

133 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q4 2019, worth a combined $1.3B — up 337% from $298M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ITCI positions and 24 closed out — a net gain of 7 holders — while 36 added to existing stakes and 47 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $23.5M. The largest seller was Wasatch Advisors, cutting an estimated $26.8M.

  • 133 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q4 2019, up from 126 in Q3 2019.
  • Funds reported $1.3B of Intra-Cellular Therapies Inc. stock for Q4 2019, up 337% quarter-over-quarter.
  • 31 funds opened new Intra-Cellular Therapies Inc. positions in Q4 2019 and 24 closed out, a net change of +7 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q4 2019 was Consonance Capital Management, an estimated $23.5M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q4 2019 was Wasatch Advisors, an estimated $26.8M sold.

Based on aggregated 13F filings for Q4 2019.